Empagliflozin 25 MG trials for Type 2 diabetes

All Empagliflozin 25 MG trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Empagliflozin 25 MG for Type 2 diabetes

• Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
  NCT05501483 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 70 Years · Sex: All (male and female) · 1 location
• SGLT2i, Hepatic Glucose Production, and SNS
  NCT07053293 · Phase: Early Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
  NCT07053306 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• SGLT2i, Pioglitazone, and Ketone Production in T2D
  NCT07053319 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• SGLTi, Hepatic Glucose Production and Ketogenesis
  NCT05960656 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
  NCT06578676 · Phase: Phase 1 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Empagliflozin 25 MG for Type 2 diabetes?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.